Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

prostate cancer

  • Open Access
    Impact of Cyclin-dependent Kinase Inhibitor 1A Genotypes on Prostate Cancer Susceptibility Prediction
    CHENG-HSI LIAO, DA-TIAN BAU, BO-REN WANG, SHU-YU CHANG, TE-CHUN HSIA, HSU-TUNG LEE, JAW-CHYUN CHEN, WEN-CHIN HUANG, CHIA-WEN TSAI, YUN-CHI WANG, HOU-YU SHIH and WEN-SHIN CHANG
    In Vivo November 2025, 39 (6) 3184-3194; DOI: https://doi.org/10.21873/invivo.14118
  • Open Access
    Urinary Metabolites as Biomarkers of Early Radiation Cystitis in Patients With Prostate Cancer Undergoing Radiotherapy
    SACHIKA SHIRAISHI, MASAHIRO SUGIMOTO and KOICHI TOKUUYE
    In Vivo July 2025, 39 (4) 2091-2100; DOI: https://doi.org/10.21873/invivo.14004
  • Open Access
    Potential Common Molecular Mechanisms Between Periodontitis and Prostate Cancer: A Network Analysis of Differentially Expressed miRNAs
    AYLIN KANLI, DENİZ SUNNETCI-AKKOYUNLU, NURHAN KULCU-SARIKAYA, CANSU UGURTAŞ, GURLER AKPINAR and MURAT KASAP
    In Vivo March 2025, 39 (2) 795-809; DOI: https://doi.org/10.21873/invivo.13863
  • Open Access
    Claudin 18.2 Is Not a Promising Biomarker for Targeted Immunotherapy in Prostatic Cancers
    JINA BAEK, YOUNG RAN SHIM and MI-JIN GU
    In Vivo March 2025, 39 (2) 819-823; DOI: https://doi.org/10.21873/invivo.13884
  • Open Access
    Genetic Variations in TP53, RB1, and PTEN in a Selected Sample of Slovak Patients With Metastatic Castration-resistant Prostate Cancer
    KLAUDIA HIVES HOLECKOVA, MARK HIVES, MARIAN GRENDAR, HENRIETA BLAHUSIAK DROBKOVA and JAN KLIMENT
    In Vivo November 2024, 38 (6) 2610-2616; DOI: https://doi.org/10.21873/invivo.13737
  • Open Access
    PSMA PET/CT Accuracy in Diagnosing Prostate Cancer Nodes Metastases
    PIETRO PEPE, LUDOVICA PEPE, VINCENZO FIORENTINO, MARA CURDUMAN, MICHELE PENNISI and FILIPPO FRAGGETTA
    In Vivo November 2024, 38 (6) 2880-2885; DOI: https://doi.org/10.21873/invivo.13769
  • Open Access
    Oral 5-aminolevulinic Acid for Patients With Localized Prostate Cancer Undergoing Low-dose-rate Brachytherapy: AMBER Trial
    MAKITO MIYAKE, NOBUMICHI TANAKA, KENTA OHNISHI, YASUSHI NAKAI, SATOSHI ANAI, KAORU YAMAKI, ISAO ASAKAWA, NOBUTAKA NISHIMURA, TOMOMI FUJII, FUMIAKI ISOHASHI and KIYOHIDE FUJIMOTO
    In Vivo November 2024, 38 (6) 3091-3105; DOI: https://doi.org/10.21873/invivo.13794
  • Open Access
    Identification of Factors Contributing to Testosterone Recovery After Hormone Therapy Combined With External Radiation Therapy
    YUMIKO YOKOMIZO, YUSUKE ITO, TAKASHI KAWAHARA, NARIHIKO HAYASHI, YASUHIDE MIYOSHI, KAZUHIDE MAKIYAMA, MASAHARU HATA and HIROJI UEMURA
    In Vivo July 2024, 38 (4) 2074-2079; DOI: https://doi.org/10.21873/invivo.13666
  • Open Access
    Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance
    PIETRO PEPE, LUDOVICA PEPE, MICHELE PENNISI and FILIPPO FRAGGETTA
    In Vivo May 2024, 38 (3) 1300-1305; DOI: https://doi.org/10.21873/invivo.13569
  • Open Access
    Identification and Quantification of Radiotherapy-related Protein Expression in Cancer Tissues Using the Qupath Software and Prediction of Treatment Response
    TOMOKAZU HASEGAWA, MASANORI SOMEYA, TAKAAKI TSUCHIYA, MIO KITAGAWA, YUKI FUKUSHIMA, TOSHIO GOCHO, SHOH MAFUNE, RYUU OKUDA, JUNO KAGUCHI, ATSUYA OHGURO, RYO KAMIYAMA, AYATO ASHINA, YUKA TOSHIMA, YOSHIHIKO HIROHASHI, TOSHIHIKO TORIGOE and KOH-ICHI SAKATA
    In Vivo May 2024, 38 (3) 1470-1476; DOI: https://doi.org/10.21873/invivo.13593

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
In Vivo

© 2025 In Vivo

Powered by HighWire